*[GTV]: Gross Tumour Volume
*[CTV]: Clinical Target Volume
*[ITV]: Internal Target Volume
*[PTV]: Planning Target Volume
*[OAR]: Organ At Risk
*[PRV]: Planning Risk Volume
*[BT]: Brachytherapy
*[EBRT]: External Body Radiation Therapy
*[Linac]: Linear Accelerator
*[AP-PA]: Anterior-Posterior, Posterior-Anterior
*[3D-CRT]: 3-Dimensional Conformal Radiation Therapy
*[IMRT]: Intensity-Modulated Radiation Therapy
*[VMAT]: Volumetric Modulated Arc Therapy
*[IGRT]: Image-Guided Radiation Therapy
*[SABR]: Stereotactic Ablative Body Radiotherapy
*[SBRT]: Stereotactic Body Radiation Therapy
*[SRS]: Stereotactic RadioSurgery
*[SRT]: Stereotactic Radiation Therapy
*[RFA]: RadioFrequency Ablation
*[TACE]: Trans-Arterial Chemo-Embolization
*[TARE]: Trans-Arterial Radio-Embolization
*[SIRT]: Selective Internal Radiation Therapy
*[RANZCR]: Royal Australian and New Zealand College of Radiology
*[RCR]: Royal College of Radiologists
*[FRO]: Faculty of Radiation Oncology
*[ASTRO]: American Society for Radiation Oncology
*[ESTRO]: European Society for Radiotherapy & Oncology
*[RTOG]: Radiation Therapy Oncology Group
*[TROG]: Trans-Tasman Radiation Oncology Group
*[ARPANSA]: Australian Radiation Protection And Nuclear Safety Agency
*[IAEA]: International Atomic Energy Agency
*[ISO]: International Organisation for Standardisation
*[NCCN]: National Comprehensive Cancer Network
*[UICC]: Union of International Cancer Control
*[AJCC]: American Joint Committee on Cancer
*[MSAC]: Medical Services Advisory Committee
*[NHMRC]: National Health and Medical Research Council
*[PBS]: Pharmaceutical Benefits Scheme
*[MBS]: Medicare Benefits Schedule
*[XR]: X-Ray
*[CT]: Computerised Tomography
*[MRI]: Magnetic Resonance Imaging
*[US]: Ultrasound
*[PET]: Positron-Emission Tomography
*[FDG]: FluoroDeoxyGlucose
*[PSMA]: Prostate-Specific Membrane Antigen
*[SPECT]: Single-Photon Emission Computed Tomography
*[RECIST]: Response Evaluation Criteria In Solid Tumors
*[CBCT]: Cone Beam CT (Computerised Tomography)
*[DVH]: Dose Volume Histogram
*[DRR]: Digitally Reconstructed Radiograph
*[MLC]: Multi-Leaf Collimator
*[ROMP]: Radiation Oncology Medical Physicist
*[RT]: Radiation Therapist
*[MV]: MegaVoltage
*[kV]: kiloVoltage
*[QA]: Quality Assurance
*[ECOG]: Eastern Co-operative Oncology Group 
*[KPS]: Karnofsky Performance Status
*[RCT]: Randomised Controlled Trial
*[OS]: Overall Survival
*[DFS]: Disease-Free Survival
*[PFS]: Progression-Free Survival
*[LC]: Local Control
*[HRQoL]: Health-Related Quality of Life
*[QoL]: Quality of Life
*[QALY]: Quality-Adjusted Life Year
*[LQ]: Linear-Quadratic model
*[EQD2]: Equivalent Dose in 2 Gy fractions
*[BED]: Biologically Effective Dose
*[PSA]: Prostate-Specific Antigen
*[EMR]: Electronic Medical Record
*[CPD]: Continuing Professional Development
*[MDT]: Multi-Disciplinary Team
*[MDM]: Multi-Disciplinary Team Meeting
*[RSS]: Really Simple Syndication
*[CTRO]: Clinical and Translational Radiation Oncology
*[Green Journal]: Radiotherapy and Oncology
*[IJPT]: International Journal of Particle Therapy
*[JCO]: Journal of Clinical Oncology
*[JMIRO]: Journal of Medical Imaging and Radiation Oncology
*[NEJM]: New England Journal of Medicine
*[PRO]: Practical Radiation Oncology
*[Red Journal]: International Journal of Radiation Oncology, Biology, Physics